← Back to Search

Behavioral Intervention

Messaging plus incentive for Flu Vaccine

N/A
Waitlist Available
Research Sponsored by The University of Texas Health Science Center at Tyler
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Enrollment in Sendero IdealCare health plan as of August 1, 2018
Age 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three months
Awards & highlights

Study Summary

• This study will assess the effect of promotional messaging and incentives encouraging influenza vaccination in the Sendero IdealCare policy holders during the 2018-2019 Flu Season. The intervention will consist of influenza vaccination promotion/reminders from Sendero Health Plans to subscribers, including text messages, emails, and tailored direct mail outs, i.e. postcard or a personalized letter, and incentive. The study population consists of approximately 22,500 subscribers enrolled in Sendero IdealCare Plan. The intervention will last approximately four months. The primary endpoints, assessed through administrative claims data, will be getting a flu shot during the 2018-2019 season. Data collected through this study will be used to determine effective components of influenza vaccination promotion campaigns used by a health insurance plan.

Eligible Conditions
  • Flu Vaccine

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three months
This trial's timeline: 3 weeks for screening, Varies for treatment, and three months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Influenza vaccination

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Messaging plus incentiveExperimental Treatment2 Interventions
Group will be sent flu vaccine promotion messages via text, email and U.S. Mail, and will be eligible to receive a gift card as incentive for receiving flu vaccine
Group II: MessagingExperimental Treatment1 Intervention
Group will be sent flu vaccine promotion messages via text, email and U.S. Mail
Group III: ControlActive Control1 Intervention
No intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Messaging
2022
N/A
~79480
Incentive
2008
Completed Phase 3
~67070

Find a Location

Who is running the clinical trial?

Sendero Health Plans, Inc.UNKNOWN
The University of Texas Health Science Center at TylerLead Sponsor
14 Previous Clinical Trials
3,104 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3520 spots leftby Mar 2025